Literature DB >> 12867551

What makes resistance to methicillin heterogeneous?

Susanne Rohrer1, Hideki Maki1, Brigitte Berger-Bächi1.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12867551     DOI： 10.1099/jmm.0.05176-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


× No keyword cloud information.
  17 in total

1.  Fitness cost of SCCmec and methicillin resistance levels in Staphylococcus aureus.

Authors:  Miriam Ender; Nadine McCallum; Rajan Adhikari; Brigitte Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

2.  Activity of oxacillin versus that of vancomycin against oxacillin-susceptible mecA-positive Staphylococcus aureus clinical isolates evaluated by population analyses, time-kill assays, and a murine thigh infection model.

Authors:  Maria Labrou; George Michail; Eleni Ntokou; Theodore E Pittaras; Spyros Pournaras; Athanassios Tsakris
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

3.  Role of the mecA gene in oxacillin resistance in a Staphylococcus aureus clinical strain with a pvl-positive ST59 genetic background.

Authors:  Feng-Jui Chen; Chen-Her Wang; Ching-Yi Chen; Yu-Chieh Hsu; Kaun-Ting Wang
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

4.  Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistance.

Authors:  Regina Fernandez; Liliana I Paz; Roberto R Rosato; Adriana E Rosato
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

5.  Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.

Authors:  Sheila Adams-Sapper; Shantell Nolen; Grace Fox Donzelli; Mallika Lal; Kunihiko Chen; Livia Helena Justo da Silva; Beatriz M Moreira; Lee W Riley
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

6.  VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.

Authors:  Shrenik Mehta; Arabela X Cuirolo; Konrad B Plata; Sarah Riosa; Jared A Silverman; Aileen Rubio; Roberto R Rosato; Adriana E Rosato
Journal:  Antimicrob Agents Chemother       Date:  2011-10-10       Impact factor: 5.191

7.  An exploratory study of methicillin-resistant Staphylococcus aureus and SCCmec elements obtained from a community setting along the Texas border with Mexico.

Authors:  David R Ammons; Raghuveer Puttagunta; Jose C Granados; Georgina de la Garza; George S Eyambe; Joanne Rampersad
Journal:  Curr Microbiol       Date:  2009-11-24       Impact factor: 2.188

8.  In vitro and in vivo evaluations of oxacillin efficiency against mecA-positive oxacillin-susceptible Staphylococcus aureus.

Authors:  Alexandros Ikonomidis; George Michail; Afroditi Vasdeki; Maria Labrou; Vasilis Karavasilis; Constantinos Stathopoulos; Antonios N Maniatis; Spyros Pournaras
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

9.  Heteroresistance to penicillin in Streptococcus pneumoniae.

Authors:  Brigitte Morand; Kathrin Mühlemann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-17       Impact factor: 11.205

Review 10.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.